Enfusion's Q1 2023 results showed double-digit revenue growth driven by new sales across products and services, with focused expense discipline maintaining a solid margin profile and strong cash conversion leading to positive adjusted free cash flow.
Enfusion's Q1 client wins demonstrate ongoing strength in conversions and further global expansion.
Signed a multi-billion-dollar venture capital fund replacing outdated technology with a cloud-native, end-to-end platform.
Signed a credit hedge fund through a relationship with Innocap Global Investment Management.
Signed a multi-billion dollar Chinese hedge fund based in Singapore, consolidating providers onto one platform.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance